Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells. (Q52085890)

21 April 2018

title

Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells. (English)

1 reference

21 April 2018

1 reference

3

1 reference

21 April 2018

Gilbert G Privé

object named as

Gilbert G Prive

7

0 references

Jose M Polo

object named as

Jose M Polo

1

0 references

Leandro Cerchietti

object named as

Leandro Cerchietti

4

0 references

author name string

Tania Dell'Oso

2

1 reference

21 April 2018

David Beck

5

1 reference

21 April 2018

Gustavo F Da Silva

6

1 reference

21 April 2018

Jonathan D Licht

8

1 reference

21 April 2018

Ari Melnick

9

1 reference

21 April 2018

language of work or name

English

0 references

publication date

7 November 2004

1 reference

21 April 2018

published in

Nature Medicine

1 reference

21 April 2018

volume

10

1 reference

21 April 2018

issue

12

1 reference

21 April 2018

page(s)

1329-1335

1 reference

21 April 2018

BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control.

cites work

1 reference

7 January 2021

The proto-oncogene BCL-6 in normal and malignant B cell development

1 reference

7 January 2021

Ambivalent role of BCL6 in cell survival and transformation

1 reference

7 January 2021

Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain

1 reference

7 January 2021

Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors.

1 reference

7 January 2021

A transcriptional co-repressor that interacts with nuclear hormone receptors

1 reference

7 January 2021

Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor

1 reference

7 January 2021

A SANT motif in the SMRT corepressor interprets the histone code and promotes histone deacetylation

1 reference

7 January 2021

ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein.

1 reference

7 January 2021

Protein transduction: unrestricted delivery into all cells?

1 reference

7 January 2021

The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.

1 reference

7 January 2021

Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B

1 reference

7 January 2021

BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells

1 reference

7 January 2021

Molecular cytogenetic characterization of non-Hodgkin lymphoma cell lines.

1 reference

7 January 2021

Control of inflammation, cytokine expression, and germinal center formation by BCL-6

1 reference

7 January 2021

Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6.

1 reference

7 January 2021

Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4

1 reference

7 January 2021

Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: specific regulation of iepsilon transcription and immunoglobulin E switching

1 reference

7 January 2021

Triggering through CD40 promotes interleukin-4-induced CD23 production and enhanced soluble CD23 release in atopic disease

1 reference

7 January 2021

The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation

1 reference

7 January 2021

BCL-6 regulates chemokine gene transcription in macrophages

1 reference

7 January 2021

In vivo protein transduction: delivery of a biologically active protein into the mouse

1 reference

7 January 2021

Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas

1 reference

7 January 2021

Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene

1 reference

7 January 2021

MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation

1 reference

7 January 2021

Histone deacetylases as therapeutic targets in hematologic malignancies

1 reference

7 January 2021

A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells

1 reference

7 January 2021

Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1134

1 reference

21 April 2018

1 reference

21 April 2018